Endoscopy 2013; 45(11): 866-868
© Georg Thieme Verlag KG Stuttgart · New York Choosing weapons in Barrett’s esophagus
Nicholas J. Shaheen
Division of Gastroenterology and Hepatology, Center for Esophageal Diseases and Swallowing,
University of North Carolina at Chapel Hill, North Carolina, USA
› Institutsangaben
References
1 Sampliner RE, Hixson LJ, Fennerty MB et al. Regression of Barrett’s esophagus by
laser ablation in an anacid environment. Dig Dis Sci 1993; 38: 365-368 2 Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett’s esophagus with acid suppression
and multipolar electrocoagulation: preliminary results. Gastrointest Endosc 1996;
44: 532-535 3 Berenson MM, Johnson TD, Markowitz NR et al. Restoration of squamous mucosa after
ablation of Barrett’s esophageal epithelium. Gastroenterology 1993; 104: 1686-1691
4 Jovov B, Shaheen NJ, Orlando GS et al. Defective barrier function in neosquamous
epithelium. Am J Gastroenterol 2013; 108: 386-391 5 Pouw RE, Gondrie JJ, Rygiel AM et al. Properties of the neosquamous epithelium after
radiofrequency ablation of Barrett’s esophagus containing neoplasia. Am J Gastroenterol
2009; 104: 1366-1373 6 Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett’s esophagus
with dysplasia. N Engl J Med 2009; 360: 2277-2288 7 Overholt BF, Lightdale CJ, Wang KK et al. Photodynamic therapy with porfimer sodium
for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially
blinded, randomized phase III trial. Gastrointest Endosc 2005; 62: 488-498 8 Dulai GS, Jensen DM, Cortina G et al. Randomized trial of argon plasma coagulation
vs. multipolar electrocoagulation for ablation of Barrett’s esophagus. Gastrointest
Endosc 2005; 61: 232-240 9 Fleischer DE, Overholt BF, Sharma VK et al. Endoscopic radiofrequency ablation for
Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy
2010; 42: 781-789 10 Ganz RA, Overholt BF, Sharma VK et al. Circumferential ablation of Barrett’s esophagus
that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc
2008; 68: 35-40 11 Barham CP, Jones RL, Biddlestone LR et al. Photothermal laser ablation of Barrett’s
oesophagus: endoscopic and histological evidence of squamous re-epithelialisation.
Gut 1997; 41: 281-284 12 Weston AP, Sharma P. Neodymium:yttrium-aluminum garnet contact laser ablation of
Barrett’s high grade dysplasia and early adenocarcinoma. Am J Gastroenterol 2002;
97: 2998-3006 13 Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett’s esophagus
with dysplasia and/or early stage carcinoma: Long-term results. Gastrointest Endosc
2003; 58: 183-188 14 Ackroyd R, Kelty CJ, Brown NJ et al. Eradication of dysplastic Barrett’s oesophagus
using photodynamic therapy: long-term follow-up. Endoscopy 2003; 35: 496-501 15 Shaheen NJ, Greenwald BD, Peery AF et al. Safety and efficacy of endoscopic spray
cryotherapy for Barrett’s esophagus with high-grade dysplasia. Gastrointest Endosc
2010; 71: 680-685 16 Dumot JA, Vargo JJ, Falk GW et al. An open-label, prospective trial of cryospray
ablation for Barrett’s esophagus high-grade dysplasia and early esophageal cancer
in high-risk patients. Gastrointest Endosc 2009; 70: 635-644 17 Sie C, Bright T, Schoeman M et al. Argon plasma coagulation ablation versus endoscopic
surveillance of Barrett’s esophagus: late outcomes from two randomized trials. Endoscopy
2013; 45: 859-865 18 Ackroyd R, Tam W, Schoeman M et al. Prospective randomized controlled trial of argon
plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett’s
esophagus after antireflux surgery. Gastrointest Endosc 2004; 59: 1-7 19 Bright T, Watson DI, Tam W et al. Randomized trial of argon plasma coagulation versus
endoscopic surveillance for barrett esophagus after antireflux surgery: late results.
Ann Surg 2007; 246: 1016-1020 20 Bright T, Watson DI, Tam W et al. Prospective randomized trial of argon plasma coagulation
ablation versus endoscopic surveillance of Barrett’s esophagus in patients treated
with antisecretory medication. Dig Dis Sci 2009; 54: 2606-2611 21 Sharma P, Wani S, Weston AP et al. A randomised controlled trial of ablation of Barrett’s
oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination
with acid suppression: long term results. Gut 2006; 55: 1233-1239 22 Ragunath K, Krasner N, Raman VS et al. Endoscopic ablation of dysplastic Barrett’s
oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized
prospective trial assessing efficacy and cost-effectiveness. Scand J Gastroenterol
2005; 40: 750-758 23 Hage M, Siersema PD, van Dekken H et al. 5-aminolevulinic acid photodynamic therapy
versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised
trial. Gut 2004; 53: 785-790 24 Kelty CJ, Ackroyd R, Brown NJ et al. Endoscopic ablation of Barrett’s oesophagus:
a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.
Aliment Pharmacol Ther 2004; 20: 1289-1296 25 Greenwald BD, Dumot JA, Horwhat JD et al. Safety, tolerability, and efficacy of endoscopic
low-pressure liquid nitrogen spray cryotherapy in the esophagus. Dis Esophagus 2009;
23: 13-19 26 Gosain S, Mercer K, Twaddell WS et al. Liquid nitrogen spray cryotherapy in Barrett’s
esophagus with high-grade dysplasia: long-term results. Gastrointest Endosc 2013;
78: 260-265 27 Van Vilsteren FG, Pouw RE, Seewald S et al. Stepwise radical endoscopic resection
versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia
or early cancer: a multicentre randomised trial. Gut 2011; 60: 765-773
